EUVIMEDEUVIMED entdecken
Leserbrief

Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests

Paul J Limburg, A Mark Fendrick, Thomas F Imperiale, John B Kisiel

Clinical Gastroenterology and Hepatology · 2026-08 · 24 (8) · 2325-2326

DOI: 10.1016/j.cgh.2025.10.033 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-08. Verfasst von Paul J Limburg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Exact Sciences Corporation, Madison, Wisconsin. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Exact Sciences Corporation, Madison, Wisconsin.
  • Division of General Medicine, University of Michigan, Ann Arbor, Michigan.
  • Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Zitieren

APA

Limburg, P. J., Fendrick, A. M., Imperiale, T. F., & Kisiel, J. B. (2026). Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests. Clinical Gastroenterology and Hepatology, 24(8), 2325-2326. https://doi.org/10.1016/j.cgh.2025.10.033

Vancouver

Limburg PJ, Fendrick AM, Imperiale TF, Kisiel JB. Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests. Clinical Gastroenterology and Hepatology. 2026;24(8):2325-2326. doi:10.1016/j.cgh.2025.10.033

BibTeX
@article{Limburg2026,
  author = {Limburg, Paul J and Fendrick, A Mark and Imperiale, Thomas F and Kisiel, John B},
  title = {Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {8},
  pages = {2325--2326},
  doi = {10.1016/j.cgh.2025.10.033}
}
Kostenlos starten →